FedEx takes precautionary steps to manage CO2 outgassing in their newest B-777 aircraft
This is a problem that confronts air carriers of temperature-sensitive products, more than the manufacturers themselves, but pharma shippers will have to factor it into their logistics plans in certain circumstances nonetheless. Dry ice—frozen CO2—has been a traditional source of cold to keep temperature-sensitive products at specified temperature (usually, 2-8°C). According to Richard Smith, managing director of the Healthcare Solutions business unit at FedEx (Memphis), the latest generation of Boeing 700-series aircraft (with which FedEx is updating its air-cargo fleet) achieves its higher energy efficiencies, in part, through tight controls on the cabin environment. As a result, if a large shipment of temperature-sensitive pharmaceuticals are being conveyed, and those pharmaceuticals are cooled by dry ice packages, the cabin environment can be affected. There are numerous technical solutions: using phase-change materials or liquid nitrogen for refrigeration, or deploying battery-powered containers with battery-powered refrigeration units; or even limiting the quantity of CO2-containing packages in the shipment. But the upshot is that the quantity of CO2 onboard, and the rate at which it evaporates, needs to be factored into a flight.
Smith, speaking at the Opal Events Pharmaceutical Supply Chain Summit (Baltimore, June 6), also detailed a service that the company is now offering for shipment of controlled room-temperature (CRT) drugs (usually, 15-30°C). Numerous shippers are now deploying engineered thermal blankets around pallets of drug, to protect the shipment from extreme high or low temperatures. Many times, the blanket is considered a disposable item at the end of the shipment. But, by offering blankets FedEx has purchased essentially as a rental service to shippers, and recycling the blankets for new shipments, FedEx can lower the overall shipping expense. FedEx uses blankets from Amsafe, Inc. (Phoenix); Smith says that they have proved especially popular for shipment runs from India to the US.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.